Observational Study of Correction of Anaemia With Darbepoetin Alfa at QM Dosing Interval in Patients With CKD Not on Dialysis
Conditions: Anaemia; Chronic Kidney Disease (CKD)Intervention: Sponsor: AmgenRecruiting - verified October 2014
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials